JHDCX | JHQDX | JHDCX / JHQDX | |
Total Expense Ratio | 1.35 | 0.59 | 229% |
Annual Report Gross Expense Ratio | 1.35 | 0.59 | 229% |
Fund Existence | 4 years | 4 years | - |
Gain YTD | 0.325 | 0.676 | 48% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.14B | 5.14B | 100% |
Annual Yield % from dividends | 0.07 | 0.74 | 9% |
Returns for 1 year | 6.56 | 7.38 | 89% |
Returns for 3 years | 25.88 | 28.41 | 91% |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PAPTX | 10.90 | -0.03 | -0.27% |
PACE Alternative Strategies P2 | |||
MALOX | 20.20 | -0.16 | -0.79% |
BlackRock Global Allocation Instl | |||
OGINX | 44.73 | -0.44 | -0.97% |
Invesco Global Opportunities R | |||
ECHSX | 12.96 | -0.14 | -1.07% |
Eaton Vance Worldwide Health Sci C | |||
GFVSX | 15.37 | -0.20 | -1.28% |
Goldman Sachs Focused Value Instl |